Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:LABD NASDAQ:LFSC NYSEARCA:RXL NYSEARCA:SURI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABDDirexion Daily S&P Biotech Bear 3x Shares$5.75+1.4%$6.45$4.78▼$16.05$92.12M-2.414.73 million shs9.49 million shsLFSCF/m Emerald Life Sciences Innovation ETF$27.73-0.9%$25.57$18.78▼$27.98$64.06MN/A2,970 shs232 shsRXLProShares Ultra Health Care$41.55+1.2%$40.08$36.23▼$58.74$66.90M1.4710,883 shs775 shsSURISimplify Propel Opportunities ETF$16.31+1.3%$15.44$12.71▼$27.52$71.60M1.572,149 shs1,043 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABDDirexion Daily S&P Biotech Bear 3x Shares+1.41%+3.42%-11.94%-33.22%+2.77%LFSCF/m Emerald Life Sciences Innovation ETF-0.63%-0.16%+12.79%+20.75%+2,772,999,900.00%RXLProShares Ultra Health Care+1.24%-1.33%+3.95%+4.95%-27.62%SURISimplify Propel Opportunities ETF+1.30%+2.97%+7.94%+11.71%-32.55%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLABDDirexion Daily S&P Biotech Bear 3x SharesN/AN/AN/AN/AN/AN/AN/AN/ALFSCF/m Emerald Life Sciences Innovation ETFN/AN/AN/AN/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/AN/AN/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLABDDirexion Daily S&P Biotech Bear 3x Shares 0.00N/AN/AN/ALFSCF/m Emerald Life Sciences Innovation ETF 2.98Moderate Buy$27.73N/ARXLProShares Ultra Health Care 2.69Moderate Buy$41.55N/ASURISimplify Propel Opportunities ETF 2.61Moderate Buy$16.31N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLABDDirexion Daily S&P Biotech Bear 3x SharesN/AN/AN/AN/AN/AN/ALFSCF/m Emerald Life Sciences Innovation ETFN/AN/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLABDDirexion Daily S&P Biotech Bear 3x SharesN/AN/A0.00∞N/AN/AN/AN/AN/ALFSCF/m Emerald Life Sciences Innovation ETFN/AN/A0.00∞N/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/A24.86∞N/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLABDDirexion Daily S&P Biotech Bear 3x Shares$0.274.70%N/AN/AN/ALFSCF/m Emerald Life Sciences Innovation ETFN/AN/AN/AN/AN/ARXLProShares Ultra Health Care$0.631.52%N/AN/AN/ASURISimplify Propel Opportunities ETF$2.7216.68%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLABDDirexion Daily S&P Biotech Bear 3x SharesN/ALFSCF/m Emerald Life Sciences Innovation ETFN/ARXLProShares Ultra Health CareN/ASURISimplify Propel Opportunities ETFN/AInsider OwnershipCompanyInsider OwnershipLABDDirexion Daily S&P Biotech Bear 3x SharesN/ALFSCF/m Emerald Life Sciences Innovation ETFN/ARXLProShares Ultra Health CareN/ASURISimplify Propel Opportunities ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLABDDirexion Daily S&P Biotech Bear 3x SharesN/A16.02 millionN/ANot OptionableLFSCF/m Emerald Life Sciences Innovation ETFN/A2.31 millionN/AN/ARXLProShares Ultra Health CareN/A1.61 millionN/ANot OptionableSURISimplify Propel Opportunities ETFN/A4.39 millionN/ANot OptionableRXL, SURI, LFSC, and LABD HeadlinesRecent News About These CompaniesSimplify Propel Opportunities ETF declares $0.68 dividendJune 30, 2025 | seekingalpha.comSimplify Propel Opportunities ETF declares quarterly distribution of $0.6800March 28, 2025 | seekingalpha.comSimplify Provides Estimated Capital Gain Distribution Information for 2024November 27, 2024 | businesswire.com(SURI) Trading ReportNovember 7, 2024 | news.stocktradersdaily.comNSimplify Propel Opportunities ETF (SURI)October 20, 2024 | investing.comSURI Simplify Propel Opportunities ETFOctober 18, 2024 | seekingalpha.com(SURI) On The My Stocks PageOctober 16, 2024 | news.stocktradersdaily.comNBest-Performing ETFs of Last WeekSeptember 24, 2024 | zacks.comMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025An Atomic Sized Surge Is Brewing for NuScale Power Stock PriceBy Thomas Hughes | August 11, 20253 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 2025Ethereum Near All-Time High: 3 Stocks Stacking ETH in TreasuriesBy Dan Schmidt | August 15, 2025RXL, SURI, LFSC, and LABD Company DescriptionsDirexion Daily S&P Biotech Bear 3x Shares NYSEARCA:LABD$5.75 +0.08 (+1.41%) Closing price 08/29/2025 04:10 PM EasternExtended Trading$5.76 +0.01 (+0.17%) As of 08/29/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.F/m Emerald Life Sciences Innovation ETF NASDAQ:LFSC$27.73 -0.25 (-0.89%) Closing price 08/29/2025 03:45 PM EasternExtended Trading$27.73 0.00 (0.00%) As of 08/29/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.ProShares Ultra Health Care NYSEARCA:RXL$41.55 +0.51 (+1.24%) Closing price 08/29/2025 04:10 PM EasternExtended Trading$41.55 0.00 (0.00%) As of 08/29/2025 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProShares Ultra Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.Simplify Propel Opportunities ETF NYSEARCA:SURI$16.31 +0.21 (+1.30%) Closing price 08/29/2025 04:10 PM EasternExtended Trading$16.06 -0.25 (-1.56%) As of 08/29/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Simplify Propel Opportunities ETF (SURI) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities SURI was launched on Feb 7, 2023 and is managed by Simplify. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It 3 Reasons Gartner Could Be the Best Buy of Q3 NIO Just Got Its Second Upgrade of the Month, and It’s Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
